» Articles » PMID: 35274490

Association of Chronic Heart Failure with Mortality in Old Intensive Care Patients Suffering from Covid-19

Abstract

Aims: Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID-19). This prospective international multicentre study investigates the role of pre-existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID-19.

Methods And Results: Patients with pre-existing CHF were subclassified as having ischaemic or non-ischaemic cardiac disease; patients with a documented ejection fraction (EF) were subclassified according to heart failure EF: reduced (HFrEF, n = 132), mild (HFmrEF, n = 91), or preserved (HFpEF, n = 103). Associations of heart failure characteristics with the 30 day mortality were analysed in univariate and multivariate logistic regression analyses. Pre-existing CHF was reported in 566 of 3917 patients (14%). Patients with CHF were older, frailer, and had significantly higher SOFA scores on admission. CHF patients showed significantly higher crude 30 day mortality [60% vs. 48%, P < 0.001; odds ratio 1.87, 95% confidence interval (CI) 1.5-2.3] and 3 month mortality (69% vs. 56%, P < 0.001). After multivariate adjustment for confounders (SOFA, age, sex, and frailty), no independent association of CHF with mortality remained [adjusted odds ratio (aOR) 1.2, 95% CI 0.5-1.5; P = 0.137]. More patients suffered from pre-existing ischaemic than from non-ischaemic disease [233 vs. 328 patients (n = 5 unknown aetiology)]. There were no differences in baseline characteristics between ischaemic and non-ischaemic disease or between HFrEF, HFmrEF, and HFpEF. Crude 30 day mortality was significantly higher in HFrEF compared with HFpEF (64% vs. 48%, P = 0.042). EF as a continuous variable was not independently associated with 30 day mortality (aOR 0.98, 95% CI 0.9-1.0; P = 0.128).

Conclusions: In critically ill older COVID-19 patients, pre-existing CHF was not independently associated with 30 day mortality.

Trial Registration Number: NCT04321265.

Citing Articles

Predicting 28-day all-cause mortality in patients admitted to intensive care units with pre-existing chronic heart failure using the stress hyperglycemia ratio: a machine learning-driven retrospective cohort analysis.

Li X, Yang X, Dong B, Liu Q Cardiovasc Diabetol. 2025; 24(1):10.

PMID: 39780223 PMC: 11714879. DOI: 10.1186/s12933-025-02577-z.


Myocarditis Associated with COVID-19 Vaccination.

Florek K, Sokolski M Vaccines (Basel). 2024; 12(10).

PMID: 39460358 PMC: 11512328. DOI: 10.3390/vaccines12101193.


Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19.

Bruno R, Wernly B, Wolff G, Fjolner J, Artigas A, Pinto B ESC Heart Fail. 2022; 9(3):1756-1765.

PMID: 35274490 PMC: 9065875. DOI: 10.1002/ehf2.13854.

References
1.
Bhatt A, Jering K, Vaduganathan M, Claggett B, Cunningham J, Rosenthal N . Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021; 9(1):65-73. PMC: 7833294. DOI: 10.1016/j.jchf.2020.11.003. View

2.
Rey J, Caro-Codon J, Rosillo S, Iniesta A, Castrejon-Castrejon S, Marco-Clement I . Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020; 22(12):2205-2215. PMC: 7461427. DOI: 10.1002/ejhf.1990. View

3.
Chague F, Boulin M, Eicher J, Bichat F, Saint Jalmes M, Cransac-Miet A . Impact of lockdown on patients with congestive heart failure during the coronavirus disease 2019 pandemic. ESC Heart Fail. 2020; 7(6):4420-4423. PMC: 7537025. DOI: 10.1002/ehf2.13016. View

4.
Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi A, Rivas-Lasarte M . Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2020; 76(20):2334-2348. PMC: 7598769. DOI: 10.1016/j.jacc.2020.09.549. View

5.
Smorenberg A, Peters E, van Daele P, Nossent E, Muller M . How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur J Intern Med. 2020; 83:1-5. PMC: 7703548. DOI: 10.1016/j.ejim.2020.11.024. View